These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 8453721)
1. K-ras and p53 point mutations in 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced hamster lung tumors. Oreffo VI; Lin HW; Padmanabhan R; Witschi H Carcinogenesis; 1993 Mar; 14(3):451-5. PubMed ID: 8453721 [TBL] [Abstract][Full Text] [Related]
2. K-ras mutations in lung tumors from A/J and A/J x TSG-p53 F1 mice treated with 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and phenethyl isothiocyanate. Matzinger SA; Crist KA; Stoner GD; Anderson MW; Pereira MA; Steele VE; Kelloff GJ; Lubet RA; You M Carcinogenesis; 1995 Oct; 16(10):2487-92. PubMed ID: 7586156 [TBL] [Abstract][Full Text] [Related]
3. Dose-dependent ras mutation spectra in N-nitrosodiethylamine induced mouse liver tumors and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induced mouse lung tumors. Chen B; Liu L; Castonguay A; Maronpot RR; Anderson MW; You M Carcinogenesis; 1993 Aug; 14(8):1603-8. PubMed ID: 8353844 [TBL] [Abstract][Full Text] [Related]
4. Mutational analysis of a dominant oncogene (c-Ki-ras-2) and a tumor suppressor gene (p53) in hamster lung tumorigenesis. Oreffo VI; Lin HW; Gumerlock PH; Kraegel SA; Witschi H Mol Carcinog; 1992; 6(3):199-202. PubMed ID: 1445620 [TBL] [Abstract][Full Text] [Related]
5. G to A transitions and G to T transversions in codon 12 of the Ki-ras oncogene isolated from mouse lung tumors induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and related DNA methylating and pyridyloxobutylating agents. Ronai ZA; Gradia S; Peterson LA; Hecht SS Carcinogenesis; 1993 Nov; 14(11):2419-22. PubMed ID: 7902220 [TBL] [Abstract][Full Text] [Related]
6. Effects of K-ras gene mutations in the development of lung lesions induced by 4-(N-methyl-n-nitrosamino)-1-(3-pyridyl)-1-butanone in A/J mice. Kawano R; Takeshima Y; Inai K Jpn J Cancer Res; 1996 Jan; 87(1):44-50. PubMed ID: 8609047 [TBL] [Abstract][Full Text] [Related]
7. Ki-ras mutations in 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-initiated and butylated hydroxytoluene-promoted lung tumors in A/J mice. Matzinger SA; Gunning WT; You M; Castonguay A Mol Carcinog; 1994 Sep; 11(1):42-8. PubMed ID: 7916989 [TBL] [Abstract][Full Text] [Related]
8. Comparative carcinogenicity and metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and N'-nitrosonornicotine in Syrian golden hamsters. Hoffmann D; Castonguay A; Rivenson A; Hecht SS Cancer Res; 1981 Jun; 41(6):2386-93. PubMed ID: 7237437 [TBL] [Abstract][Full Text] [Related]
9. Transformation of hamster pancreatic duct cells by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), in vitro. Baskaran K; Laconi S; Reddy MK Carcinogenesis; 1994 Nov; 15(11):2461-6. PubMed ID: 7955092 [TBL] [Abstract][Full Text] [Related]
10. Comparison of pulmonary O6-methylguanine DNA adduct levels and Ki-ras activation in lung tumors from resistant and susceptible mouse strains. Devereux TR; Belinsky SA; Maronpot RR; White CM; Hegi ME; Patel AC; Foley JF; Greenwell A; Anderson MW Mol Carcinog; 1993; 8(3):177-85. PubMed ID: 8216736 [TBL] [Abstract][Full Text] [Related]
11. Role of ras protooncogene activation in the formation of spontaneous and nitrosamine-induced lung tumors in the resistant C3H mouse. Devereux TR; Anderson MW; Belinsky SA Carcinogenesis; 1991 Feb; 12(2):299-303. PubMed ID: 1995195 [TBL] [Abstract][Full Text] [Related]
13. Role of the alveolar type II cell in the development and progression of pulmonary tumors induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in the A/J mouse. Belinsky SA; Devereux TR; Foley JF; Maronpot RR; Anderson MW Cancer Res; 1992 Jun; 52(11):3164-73. PubMed ID: 1591728 [TBL] [Abstract][Full Text] [Related]
14. Relationship between the formation of promutagenic adducts and the activation of the K-ras protooncogene in lung tumors from A/J mice treated with nitrosamines. Belinsky SA; Devereux TR; Maronpot RR; Stoner GD; Anderson MW Cancer Res; 1989 Oct; 49(19):5305-11. PubMed ID: 2670201 [TBL] [Abstract][Full Text] [Related]
15. Alterations in the K-ras and p53 genes in rat lung tumors. Belinsky SA; Swafford DS; Finch GL; Mitchell CE; Kelly G; Hahn FF; Anderson MW; Nikula KJ Environ Health Perspect; 1997 Jun; 105 Suppl 4(Suppl 4):901-6. PubMed ID: 9255578 [TBL] [Abstract][Full Text] [Related]
16. Histochemical characterization of non-neuroendocrine tumors and neuroendocrine cell hyperplasia induced in hamster lung by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone with or without hyperoxia. Sunday ME; Willett CG; Graham SA; Oreffo VI; Linnoila RI; Witschi H Am J Pathol; 1995 Sep; 147(3):740-52. PubMed ID: 7677185 [TBL] [Abstract][Full Text] [Related]
17. p53 mutations in head and neck squamous cell carcinomas from Sudanese snuff (toombak) users. Lazarus P; Idris AM; Kim J; Calcagnotto A; Hoffmann D Cancer Detect Prev; 1996; 20(4):270-8. PubMed ID: 8818386 [TBL] [Abstract][Full Text] [Related]
18. Pathobiology of lung tumors induced in hamsters by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and the modulating effect of hyperoxia. Schuller HM; Witschi HP; Nylen E; Joshi PA; Correa E; Becker KL Cancer Res; 1990 Mar; 50(6):1960-5. PubMed ID: 2306745 [TBL] [Abstract][Full Text] [Related]
19. Frequent mutations of Ki-ras but no mutations of Ha-ras and p53 in lung lesions induced by N-nitrosobis(2-hydroxypropyl)amine in rats. Kitada H; Tsutsumi M; Tsujiuchi T; Takahama M; Fukuda T; Narita N; Konsihi Y Mol Carcinog; 1996 Apr; 15(4):276-83. PubMed ID: 8634086 [TBL] [Abstract][Full Text] [Related]
20. p53 and Ha-ras mutations in chemically induced hamster buccal pouch carcinomas. Chang KW; Lin SC; Koos S; Pather K; Solt D Carcinogenesis; 1996 Mar; 17(3):595-600. PubMed ID: 8631150 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]